Nupharmisto 4% Lidocaine Numbing cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nupharmisto 4% Lidocaine Numbing cream
Generic name: LIDOCAINE 4%
Manufacturer: EveryMarket Inc
Product type: HUMAN OTC DRUG
SPL set ID: 5615e49d-e03b-f915-e063-6294a90a1786
SPL ID: 5615e49d-e03c-f915-e063-6294a90a1786
Version: 1
Effective date: 2026-07-08
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:18:25

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Nupharmisto 4% Lidocaine Numbing cream	openfda.brand_name
generic name		LIDOCAINE 4%	openfda.generic_name
manufacturer name		EveryMarket Inc	openfda.manufacturer_name
ndc	package	85833-007-01	openfda.package_ndc
ndc	product	85833-007	openfda.product_ndc
ndc11	package	85833000701	derived:openfda.package_ndc
rxcui		1421893	openfda.rxcui
spl id		5615e49d-e03c-f915-e063-6294a90a1786	id
spl set id		5615e49d-e03b-f915-e063-6294a90a1786	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only Stop and ask a doctor if an llergic reaction occurs. symptom does not improve or if redness, irritation, swelling, pain or other symptoms develop or increase. do not exceed the recommended daily dosage unless directed by a doctor. Avoid contact with the eyes. Do not use if you are allergic to the ingredients in this product or if the seal is broken or missing. ask a health professional before use. In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.